Heather Preston - Jun 23, 2022 Form 4 Insider Report for Akouos, Inc. (AKUS)

Role
Director
Signature
/s/ Karoline Shair, as attorney-in-fact for Heather Preston
Stock symbol
AKUS
Transactions as of
Jun 23, 2022
Transactions value $
$0
Form type
4
Date filed
6/27/2022, 05:06 PM
Previous filing
Jun 22, 2022
Next filing
Dec 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKUS Stock Option (right to buy) Award $0 +16K $0.00 16K Jun 23, 2022 Common Stock 16K $4.21 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 23, 2022. The shares underlying the option will fully vest on the earlier of (i) June 23, 2023 and (ii) the date of the Issuer's 2023 annual meeting of stockholders.
F2 The option was granted to the Reporting Person, a managing partner of Pivotal BioVenture Partners Fund I, L.P. (the "Fund") and an officer of Pivotal bioVenture Partners Investment Advisor, LLC (the "Investment Adviser"), the Fund's investment adviser, in connection with her service as a member of the Board of Directors of the Issuer. Pursuant to the policies of the Investment Adviser, the Reporting Person has assigned her rights in respect of the option to the Investment Adviser. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of her pecuniary interest therein, if any.